ArticleScientific reports2020

Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension.

Mudit Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.